Private equity investment firm Windjammer Capital Investors announced that it has acquired Bio X Cell LLC, a monoclonal antibodies producer. Financial terms were not disclosed. Newport Beach, California-based Windjammer Capital was advised by a Kirkland & Ellis team led by corporate partners Amanda Border and Christian Atwood. Counsel information for Bio X Cell, which is based in Lebanon, New Hampshire, was not immediately available.
Biotech & Pharmaceuticals
December 14, 2023, 11:28 AM